Landmark advised the shareholders of Biotay on the sale of 100% of the shares to Phibro Animal Health.
Biotay S.A. is a leading Argentine animal health and nutritional products company engaged in production, marketing and distribution within Argentina. The company specializes in bovine cattle, swine and poultry segments, and to a lesser extent horses and other species. Phibro (NASDAQ:PAHC) is a global developer, manufacturer and marketer of animal health and mineral nutrition products for the poultry, swine, dairy, cattle and aquaculture markets. PAHC’s revenues and EBITDA reached US$764 million and US$150 million in LTM June-2017, respectively.